Multiomics Identifies Potential Molecular Profiles Associated With Outcomes After BRAF-Targeted Therapy in Patients With BRAF V600E-Mutated Advanced Solid Tumors
Using a multiomic approach, we identified molecular alterations associated with treatment outcomes. The potential of analyzing multiomic data is promising and should be prioritized in translational cancer research to uncover the full potential within precision oncology.
Authors
- Martin Højgaard (ORCID: https://orcid.org/0000-0003-1850-535X)
- Christina Westmose Yde (ORCID: https://orcid.org/0000-0001-9578-9136)
- Martina Amnitzbøll Eriksen (ORCID: https://orcid.org/0000-0002-4700-2615)
- Annelaura Bach Nielsen (ORCID: https://orcid.org/0009-0005-2855-208X)
- Camilla Qvortrup (ORCID: https://orcid.org/0000-0001-9338-9841)
- Filip Mundt (ORCID: https://orcid.org/0000-0001-8622-2971)
- Kristoffer Staal Rohrberg (ORCID: https://orcid.org/0000-0002-5448-9003)
- Iben Spanggaard (ORCID: https://orcid.org/0000-0001-5925-2630)
- Lise Barlebo Ahlborn (ORCID: https://orcid.org/0000-0001-8021-7442)
- Ulrik Lassen (ORCID: https://orcid.org/0000-0002-3865-4574)
- Matthias Mann (ORCID: https://orcid.org/0000-0003-1292-4799)
- Å. Hansen (ORCID: https://orcid.org/0000-0003-2162-2864)
Institutions
- University of Copenhagen (DK)
- Novo Nordisk Foundation (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1200/po.24.00266
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00